Search

Search Constraints

You searched for: Author/Creator Daher, May

Search Results

1. 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. (10th December 2020)

2. 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. (9th November 2020)

3. 657 Interleukin-6 receptor blockade for management of immune checkpoint inhibitor related adverse events in patients with melanoma. (10th December 2020)

4. 657 Interleukin-6 receptor blockade for management of immune checkpoint inhibitor related adverse events in patients with melanoma. (9th November 2020)

5. An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes. Issue 7 (9th June 2017)

6. An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes. Issue 7 (9th June 2017)

7. Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis. Issue 12 (4th October 2021)

10. Meeting report: SMART timing—principles of single molecule techniques course at the University of Michigan 2014. Issue 5 (May 2015)